Improving Hepatitis C Treatment in Injection Drug Users
Status:
Completed
Trial end date:
2007-03-01
Target enrollment:
Participant gender:
Summary
The overall goal of the research project is to improve the outcome of medical care for
injection drug users (IDUs) with Hepatitis C viral (HCV) infection.
Hypothesis: An intervention designed to improve the rate of HCV treatment completion and
sustained virologic response (SVR) in IDUs will increase access by integrating HCV medical
care into a substance abuse treatment program.
Phase:
Phase 4
Details
Lead Sponsor:
State University of New York - Upstate Medical University